Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) FCF Margin (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed FCF Margin for 2 consecutive years, with 612.16% as the latest value for Q2 2025.

  • On a quarterly basis, FCF Margin changed N/A to 612.16% in Q2 2025 year-over-year; TTM through Sep 2025 was 2566.13%, a N/A change, with the full-year FY2024 number at 358.66%, changed N/A from a year prior.
  • FCF Margin was 612.16% for Q2 2025 at Pyxis Oncology, down from 129.73% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 129.73% in Q1 2024 to a low of 612.16% in Q2 2025.